Autifony Therapeutics' Series A - II Round

Autifony Therapeutics raised a round of funding on July 10, 2015.

Autifony Therapeutics is an independent biotechnology company focusing on the development of high value, novel medicines to treat serious diseases of the central nervous system.…

Articles about Autifony Therapeutics' Series A - II Round: